![Bharat Biotech to Ramp up Covaxin Production by 200 Million](http://media.assettype.com/english-sentinelassam%2Fimport%2Fh-upload%2F2021%2F05%2F20%2F226412-cova.webp?w=480&auto=format%2Ccompress&fit=max)
HYDERABAD: Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million. The manufacturing capacities for India's first indigenous Covid vaccine have been ramped up at Chiron Behring Vaccines, a wholly-owned subsidiary of Bharat Biotech at Ankleshwar, Gujarat. (IANS)